IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

U.K. Pseudoephedrine Curb?

11:18 AM MDT | July 27, 2007 | Chemical Week Editorial Staff

U.K. government agency the Medicines and Healthcare Products Regulatory Agency (MHRA) has proposed a reclassification of medicines containing pseudoephedrine and ephedrine as prescription-only drugs. The substances are often used in over-the-counter cold and flu treatments. The reclassification could hurt manufacturers of pseudoephedrine and ephedrine, because pharmaceutical companies may respond to the changes by formulating new medicines that omit the two products. BASF has slashed jobs and reduced psuedoephedrine production at Minden, Germany during the past...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa